• linkedin
  • Increase Font
  • Sharebar

    Novel therapies could stem burden of diabetic eye disease


    Role of immune tolerance

    Induction of immune tolerance represents another intriguing approach. Dr. Garweg cited research in which islet cells were transplanted in the anterior chamber of the eye.

    “These cells showed good survival and were well tolerated under topical corticosteroids,” he said. “During early follow-up, the treated patient had improvement in c-peptide and blood glucose.

    “It is hoped that this approach might induce immune tolerance to systemically transplanted islet cells and result in a new endogenous source of insulin production with an improvement in the outcome of diabetes and better control of diabetic retinopathy,” Dr. Garweg added.

    Similarly, it was reported in an animal model that interphotoreceptor-binding protein injection into the anterior chamber induced immune tolerance and prevented progression of diabetic retinopathy.

    “The treatment did not prevent systemic diabetic organ damage, however,” Dr. Garweg pointed out. “Therefore, the future will depend on intensified interdisciplinary networking to develop combination local and systemic therapeutic strategies.”


    Justus G. Garweg, MD

    E: [email protected]

    This article is based on a presentation given by Dr. Garweg at the 2017 Retina World Congress. Dr. Garweg is an advisor to AbbVie, Alcon Laboratories, Allergan, Bayer, and Novartis. He also is an investigator in clinical trials of treatment for diabetic retinopathy and age-related macular degeneration, sponsored by Novartis and Bayer. He has declared no conflicts of interest with the presented data.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow

    var script= ' ';